Status:
RECRUITING
Qualitative Study of Surgeons With Prospective Patient Follow-up
Lead Sponsor:
University Hospital Southampton NHS Foundation Trust
Conditions:
Necrotizing Enterocolitis
Eligibility:
All Genders
Up to 4 years
Brief Summary
Necrotising enterocolitis (NEC) is a devastating disease which causes severe bowel inflammation resulting in babies becoming critically unwell. It mainly affects premature babies (who can be born as e...
Detailed Description
Necrotising enterocolitis (NEC) predominately affects pre-term infants and consists of a severe bowel inflammation which can lead to necrosis. The number of babies at highest risk of developing NEC is...
Eligibility Criteria
Inclusion
- Infant with suspected or confirmed NEC undergoing review by surgeon, regardless of outcome of that review (I.e. surgery indicated or not).
Exclusion
- Lack of consent from surgeon to undertake interview.
- Lack of consent from parents to follow-up outcomes of infant.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2028
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT06032676
Start Date
January 1 2024
End Date
October 1 2028
Last Update
April 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Southampton NHS Foundation Trust
Southampton, Hampshire, United Kingdom, SO16 6YD